NO983100L - 4,5-dihydronaft£1,2-C|isoksazoler og derivater derav med CNS-aktivitet - Google Patents

4,5-dihydronaft£1,2-C|isoksazoler og derivater derav med CNS-aktivitet

Info

Publication number
NO983100L
NO983100L NO983100A NO983100A NO983100L NO 983100 L NO983100 L NO 983100L NO 983100 A NO983100 A NO 983100A NO 983100 A NO983100 A NO 983100A NO 983100 L NO983100 L NO 983100L
Authority
NO
Norway
Prior art keywords
dihydronaphth
derivatives
cisoxazoles
cns activity
compounds
Prior art date
Application number
NO983100A
Other languages
English (en)
Norwegian (no)
Other versions
NO983100D0 (no
Inventor
Nicholas J Hrib
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NO983100D0 publication Critical patent/NO983100D0/no
Publication of NO983100L publication Critical patent/NO983100L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO983100A 1996-01-05 1998-07-03 4,5-dihydronaft£1,2-C|isoksazoler og derivater derav med CNS-aktivitet NO983100L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US58331996A 1996-01-05 1996-01-05
PCT/US1996/019569 WO1997025317A1 (en) 1996-01-05 1996-12-12 4,5-dihydronaphth[1,2-c]isoxazoles and derivatives thereof having cns activity

Publications (2)

Publication Number Publication Date
NO983100D0 NO983100D0 (no) 1998-07-03
NO983100L true NO983100L (no) 1998-09-04

Family

ID=24332609

Family Applications (1)

Application Number Title Priority Date Filing Date
NO983100A NO983100L (no) 1996-01-05 1998-07-03 4,5-dihydronaft£1,2-C|isoksazoler og derivater derav med CNS-aktivitet

Country Status (14)

Country Link
EP (1) EP0874833A1 (zh)
JP (1) JP3161737B2 (zh)
KR (1) KR100308748B1 (zh)
CN (1) CN1214046A (zh)
AR (1) AR005347A1 (zh)
AU (1) AU710059B2 (zh)
BR (1) BR9612578A (zh)
CA (1) CA2241845C (zh)
HU (1) HUP9903706A3 (zh)
IL (1) IL125197A0 (zh)
NO (1) NO983100L (zh)
NZ (1) NZ325587A (zh)
WO (1) WO1997025317A1 (zh)
ZA (1) ZA9725B (zh)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2420235A1 (en) * 2000-08-21 2002-02-28 Georgetown University 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon
US7265103B2 (en) * 2002-04-02 2007-09-04 Janssen Pharmaceutica Nv. Substituted amino isoxazoline derivatives and their use as anti-depressants
AR040967A1 (es) 2002-08-12 2005-04-27 Janssen Pharmaceutica Nv Derivados de isoxazolina triciclicos c- sustituidos y su uso como anti- depresivos
EP1554286B1 (en) 2002-08-15 2010-01-27 Janssen Pharmaceutica N.V. Fused heterocyclic isoxazoline derivatives and their use as anti-depressants
MY134287A (en) * 2002-08-21 2007-11-30 Janssen Pharmaceutica Nv C6- and c9-substituted isoxazoline derivatives and their use as anti-depressants
US8025859B2 (en) 2007-05-18 2011-09-27 Cesl Limited Process for gold and silver recovery from a sulphide concentrate
EP2493866A1 (en) 2009-10-29 2012-09-05 Bristol-Myers Squibb Company Tricyclic heterocyclic compounds
US10633354B2 (en) 2016-09-02 2020-04-28 Bristol-Myers Squibb Company Substituted tricyclic heterocyclic compounds
US11059784B2 (en) 2017-08-09 2021-07-13 Bristol-Myers Squibb Company Oxime ether compounds
US11046646B2 (en) 2017-08-09 2021-06-29 Bristol-Myers Squibb Company Alkylphenyl compounds
KR102002633B1 (ko) 2018-07-19 2019-07-22 김태효 완충이격부가 구비된 논슬립 발의류
KR102429797B1 (ko) 2019-12-31 2022-08-05 주식회사 제이패션 기능성 무재봉 덧신 및 이를 제조하는 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2119977A1 (en) * 1971-04-23 1971-12-16 Teikoku Hormone Manufacturing Co , Ltd, Tokio Antiphlogistic and antisecretory napththisoxazoles - from 1-hydroxyim - 2-carbonyl derivs by intramolecular condensation
EP0402644B1 (en) * 1989-05-19 1995-08-16 Hoechst-Roussel Pharmaceuticals Incorporated N-(aryloxyalkyl)heteroarylpiperidines and -heteroarylpiperazines,a process for their preparation and their use as medicaments
US5670522A (en) * 1992-10-23 1997-09-23 Merck Sharp & Dohme Limited Dopamine receptor subtype ligands

Also Published As

Publication number Publication date
CN1214046A (zh) 1999-04-14
AU1412697A (en) 1997-08-01
NZ325587A (en) 1999-02-25
WO1997025317A1 (en) 1997-07-17
BR9612578A (pt) 1999-07-27
KR19990077033A (ko) 1999-10-25
AU710059B2 (en) 1999-09-09
IL125197A0 (en) 1999-03-12
KR100308748B1 (ko) 2001-12-12
CA2241845C (en) 2002-10-01
HUP9903706A3 (en) 2000-09-28
ZA9725B (en) 1997-07-07
AR005347A1 (es) 1999-04-28
JP3161737B2 (ja) 2001-04-25
NO983100D0 (no) 1998-07-03
EP0874833A1 (en) 1998-11-04
JPH11510816A (ja) 1999-09-21
CA2241845A1 (en) 1997-07-17
HUP9903706A2 (hu) 2000-08-28

Similar Documents

Publication Publication Date Title
AU6944091A (en) Indole-substituted five-membered heteroaromatic compounds
DK0491664T3 (da) Indolderivater som serotonin-antagonister
CA2086434A1 (en) Quinuclidine derivatives
NO983100L (no) 4,5-dihydronaft£1,2-C|isoksazoler og derivater derav med CNS-aktivitet
GR3036669T3 (en) O-carbamoyl-phenylalaninol having substituent at benzene ring, its pharmaceutically useful salts and method for preparing the same
DK1302207T3 (da) Fremgangsmåde til at fremstille et antihypertensivt middel indeholdende et dipeptid som virkningsfuld bestanddel
ES2152379T3 (es) Dihidropiridinas condensadas y su utilizacion para la produccion de preparados farmaceuticos.
NO974155D0 (no) Ny fremgangsmåte for fremstilling av 2,3-dihydrobenzofuranolderivater
AP2002002595A0 (en) Heterocyclic amide derivatives.
FI906084A (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 5-(2-metyyli-4,4,4-trifluoributyylikarbamoyyli)indolijohdannaisten valmistamiseksi
TW358807B (en) Processes and intermediates for preparing 3-(1-piperazinyl)-1,2-benzisothiazole
DE59010633D1 (de) 8-alpha-ACYLAMINO-ERGOLINE, IHRE HERSTELLUNG UND VERWENDUNG ALS ARZNEIMITTEL
PT889044E (pt) Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central
BG105247A (en) N-substituted azabicycloheptane derivatives, production and use thereof
TW200504081A (en) N-sulfonylaminothiazole
CA2275299A1 (en) Indane or dihydroindole derivatives
HUP0002895A2 (hu) 3-Azabiciklo[3.1.0]hexánok, eljárás előállításukra és alkalmazásuk
NO20012538L (no) Anvendelse av N-substituerte azabicycloalkanderivater for behandling av forstyrrelser i sentralnervesystemet
EP0686641A4 (en) 2'-DESOXY-5-FLUOROURIDINE DERIVATIVE, PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PROCESS FOR PRODUCING SAME AND ANTI-TUMOR MEDICINAL PRODUCT
AU3499189A (en) Tricyclic ketones Patent to Lapse
MX9703899A (es) Derivado de arilacrilamida.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application